By Annika Kim Constantino for CNBC, published Nov 8, 2023. Read Original Article here. The Food and Drug Administration on Wednesday approved Eli Lilly’s blockbuster drug tirzepatide for weight loss, paving the way for even wider use of the treatment in the U.S. The active ingredient in the drug, tirzepatide, has already been approved for […]
By Rachel Hosie for Business Insider, published April 22, 2023. Read Original Article here. Since being approved for weight loss almost two years ago, semaglutide has been hailed as a “game-changer” Semaglutide originated as a diabetes medication but was FDA-approved to treat obesity in 2021. Semaglutide originated as a diabetes medication but was FDA-approved to
Navigating the path of 40s, 50s, and 60s, many men confront health challenges that were previously inconspicuous. Among these challenges, the emergence of visceral fat — often dubbed as ‘heart attack fat’ — becomes a pressing concern. Lurking beneath the abdominal wall, this pernicious fat is notoriously stubborn, posing heightened health risks. Thankfully, there’s Semaglutide,
Semaglutide and Tirzepatide: Combating Visceral Fat and Steering Men to Healthier Aging Read More »
Article by Jacquelyn Baker, APRN. Semaglutide and Tirzepatide For Weight Loss The rising prevalence of obesity has led to a surge in medically supervised weight loss programs that promise effective and safe solutions for those that want to lose weight in a healthy, sustainable way. You may have already heard of a few – whether
What to Know About the New Medically-Supervised Weight Loss Programs Read More »
